Direct testing, treatment, and healthcare management costs used in the modelling analyses.

This includes the unit costs of HCV screening and treatment and estimated annual costs of managing chronic HCV infection by disease progression stage. These cost estimates are used in both intervention scenarios (status quo and elimination) and for each of the economic perspectives (A, B, and C). All costs are in 2018 US dollars (US$).